LexDanaLexDanabeta
Inventor

ETIENNE THOREAU

Inventor
FR

Overview

3→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
12,583,868JAK inhibitors and methods for synthesizing and using thereof202611,731,973Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors202311,518,767MTOR inhibitor compounds2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to GALDERMA RES & DEV (2)· patent assignee history
2022–2026Based in FR· patent location history
2026Patents assigned to Galderma Holding SA (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GALDERMA RES & DEV22022–2023
Galderma Holding SA12026
Locations
LocationPatentsSpan
FR32022–2026